# Study of Obeldesivir in Children and Adolescents With COVID-19

> **NCT05996744** · PHASE2,PHASE3 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 3 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Obeldesivir

## Key facts

- **NCT ID:** NCT05996744
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2023-12-26
- **Primary completion:** 2024-02-23
- **Final completion:** 2024-02-23
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study was terminated by Sponsor; the decision was not due to any safety findings.
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05996744

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05996744, "Study of Obeldesivir in Children and Adolescents With COVID-19". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05996744. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*